Your browser doesn't support javascript.
loading
Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway.
Robsahm, T E; Tsuruda, K M; Hektoen, H H; Storås, A H; Cook, M B; Hurwitz, L M; Langseth, H.
Affiliation
  • Robsahm TE; Department of Research, Cancer Registry of Norway, Oslo, Norway.
  • Tsuruda KM; Department of Research, Cancer Registry of Norway, Oslo, Norway.
  • Hektoen HH; Department of Research, Cancer Registry of Norway, Oslo, Norway.
  • Storås AH; Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Cook MB; Department of Research, Cancer Registry of Norway, Oslo, Norway.
  • Hurwitz LM; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Langseth H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Acta Oncol ; 62(1): 8-14, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36762472
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: